HEMATOXYLIN

HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.

Cross Reference

Introduction

To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEMATOXYLIN?

HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN

MeSH term MeSH ID Detail
Lymphoma, Follicular D008224 3 associated lipids
Bone Diseases D001847 4 associated lipids
Rabies D011818 4 associated lipids
Teratoma D013724 4 associated lipids
Rodent Diseases D012376 4 associated lipids
Thyroid Nodule D016606 4 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Neoplastic Cells, Circulating D009360 5 associated lipids
Calcinosis D002114 5 associated lipids
Neoplasm Recurrence, Local D009364 5 associated lipids
Per page 10 20 50 100 | Total 146

PubChem Associated disorders and diseases

What pathways are associated with HEMATOXYLIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEMATOXYLIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEMATOXYLIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

What genes are associated with HEMATOXYLIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with HEMATOXYLIN

Download all related citations
Per page 10 20 50 100 | Total 5340
Authors Title Published Journal PubMed Link
Liu WM et al. Inhibition of metastatic potential in colorectal carcinoma in vivo and in vitro using immunomodulatory drugs (IMiDs). 2009 Br. J. Cancer pmid:19638977
Mellado B et al. Phase II trial of short-term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate cancer. 2009 Br. J. Cancer pmid:19755998
Eichenmüller M et al. Betulinic acid induces apoptosis and inhibits hedgehog signalling in rhabdomyosarcoma. 2010 Br. J. Cancer pmid:20517313
Nakagawa S et al. Analysis of the expression and localisation of a LAP protein, human scribble, in the normal and neoplastic epithelium of uterine cervix. 2004 Br. J. Cancer pmid:14710229
Hamma-Kourbali Y et al. Carboxymethyl benzylamide dextran inhibits angiogenesis and growth of VEGF-overexpressing human epidermoid carcinoma xenograft in nude mice. 2003 Br. J. Cancer pmid:12838326
Yao H et al. Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer. 2004 Br. J. Cancer pmid:15494722
Pardo FS et al. Mutant, wild type, or overall p53 expression: freedom from clinical progression in tumours of astrocytic lineage. 2004 Br. J. Cancer pmid:15494720
Kristiansen G et al. CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients. 2003 Br. J. Cancer pmid:12610508
Abd El-Rehim DM et al. Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma. 2004 Br. J. Cancer pmid:15480434
Hussain SA et al. Proapoptotic genes BAX and CD40L are predictors of survival in transitional cell carcinoma of the bladder. 2003 Br. J. Cancer pmid:12592374
Spizzo G et al. Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival. 2003 Br. J. Cancer pmid:12592372
Pelosi G et al. Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. 2003 Br. J. Cancer pmid:12592367
Millar EK et al. BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast. 2009 Br. J. Cancer pmid:19066611
Pamecha V et al. Effect of portal vein embolisation on the growth rate of colorectal liver metastases. 2009 Br. J. Cancer pmid:19209170
Li Q et al. Expression of interferon-gamma in human adrenal gland and kidney tumours. 2007 Br. J. Cancer pmid:17622250
Nishikawa M et al. Accumulation of mitochondrial DNA mutation with colorectal carcinogenesis in ulcerative colitis. 2005 Br. J. Cancer pmid:15956973
Clark SE et al. Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease. 2011 Br. J. Cancer pmid:21139586
Onda M et al. Decreased expression of haemoglobin beta (HBB) gene in anaplastic thyroid cancer and recovery of its expression inhibits cell growth. 2005 Br. J. Cancer pmid:15956966
Ni X et al. Characterisation of human kallikrein 6/protease M expression in ovarian cancer. 2004 Br. J. Cancer pmid:15305183
Fareed KR et al. Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy. 2010 Br. J. Cancer pmid:20461087
Sersa G et al. Reduced blood flow and oxygenation in SA-1 tumours after electrochemotherapy with cisplatin. 2002 Br. J. Cancer pmid:12434299
Fan LZ and Cherian MG Potential role of p53 on metallothionein induction in human epithelial breast cancer cells. 2002 Br. J. Cancer pmid:12434295
Bibi R et al. A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei. 2006 Br. J. Cancer pmid:17031402
Thews O et al. Microenvironmental adaptation of experimental tumours to chronic vs acute hypoxia. 2004 Br. J. Cancer pmid:15305198
Bruland O et al. Gene expression reveals two distinct groups of anal carcinomas with clinical implications. 2008 Br. J. Cancer pmid:18349847
Yao M et al. COX-2 selective inhibition reverses the trophic properties of gastrin in colorectal cancer. 2002 Br. J. Cancer pmid:12189559
Puppa G et al. Independent prognostic value of fascin immunoreactivity in stage III-IV colonic adenocarcinoma. 2007 Br. J. Cancer pmid:17375048
Schmitz M et al. Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy. 2007 Br. J. Cancer pmid:17375044
Comstock CE et al. Impact of differential cyclin D1 expression and localisation in prostate cancer. 2007 Br. J. Cancer pmid:17375037
Elie C et al. Lack of relationship between EGFR-1 immunohistochemical expression and prognosis in a multicentre clinical trial of 93 patients with advanced primary ovarian epithelial cancer (GINECO group). 2004 Br. J. Cancer pmid:15226774
Ogawa E et al. Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients. 2004 Br. J. Cancer pmid:15226767
Collet JF et al. Galectin-3 immunodetection in follicular thyroid neoplasms: a prospective study on fine-needle aspiration samples. 2005 Br. J. Cancer pmid:16251880
Koljonen V et al. Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma. 2009 Br. J. Cancer pmid:19755994
Shehata M et al. Human leukocyte antigen class I expression is an independent prognostic factor in advanced ovarian cancer resistant to first-line platinum chemotherapy. 2009 Br. J. Cancer pmid:19755991
Lugli A et al. CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a 'pro-/anti-tumour' approach to tumour host interaction in colorectal cancer. 2009 Br. J. Cancer pmid:19755986
Chen YL et al. Granulocytes mediates the Fas-L-associated apoptosis during lung metastasis of melanoma that determines the metastatic behaviour. 2002 Br. J. Cancer pmid:12177809
Baeten CI et al. Flow cytometric quantification of tumour endothelial cells; an objective alternative for microvessel density assessment. 2002 Br. J. Cancer pmid:12177806
Sheridan J et al. Nuclear oxidative damage correlates with poor survival in colorectal cancer. 2009 Br. J. Cancer pmid:19066606
van Beers EH et al. A multiplex PCR predictor for aCGH success of FFPE samples. 2006 Br. J. Cancer pmid:16333309
Ding SL et al. Abnormality of the DNA double-strand-break checkpoint/repair genes, ATM, BRCA1 and TP53, in breast cancer is related to tumour grade. 2004 Br. J. Cancer pmid:15138484
Patmore HS et al. Can a genetic signature for metastatic head and neck squamous cell carcinoma be characterised by comparative genomic hybridisation? 2004 Br. J. Cancer pmid:15138481
Sivridis E et al. Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis. 2002 Br. J. Cancer pmid:11986782
Hildenbrand R and Arens N Protein and mRNA expression of uPAR and PAI-1 in myoepithelial cells of early breast cancer lesions and normal breast tissue. 2004 Br. J. Cancer pmid:15226768
Ueno Y et al. Selective inhibition of TNF-alpha-induced activation of mitogen-activated protein kinases and metastatic activities by gefitinib. 2005 Br. J. Cancer pmid:15841081
Sriraksa R et al. CpG-island methylation study of liver fluke-related cholangiocarcinoma. 2011 Br. J. Cancer pmid:21448164
Kato T et al. A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity. 2005 Br. J. Cancer pmid:16251871
Dai DL et al. Reduced Apaf-1 expression in human cutaneous melanomas. 2004 Br. J. Cancer pmid:15305193
Hussain SA et al. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. 2007 Br. J. Cancer pmid:17213826
Hosono S et al. Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients. 2007 Br. J. Cancer pmid:17211477
Grützmann R et al. ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma. 2004 Br. J. Cancer pmid:14997207
Vicent S et al. ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours. 2004 Br. J. Cancer pmid:14997206
Takemoto S et al. Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma. 2009 Br. J. Cancer pmid:19638983
Lagadec P et al. Pharmacological targeting of NF-kappaB potentiates the effect of the topoisomerase inhibitor CPT-11 on colon cancer cells. 2008 Br. J. Cancer pmid:18182997
Awwad HK et al. Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation. 2002 Br. J. Cancer pmid:11870530
Mitra A et al. Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype. 2008 Br. J. Cancer pmid:18182994
Rofstad EK and Halsør EF Hypoxia-associated spontaneous pulmonary metastasis in human melanoma xenografts: involvement of microvascular hot spots induced in hypoxic foci by interleukin 8. 2002 Br. J. Cancer pmid:11870523
Cheng Q et al. Identification of molecular markers for the early detection of human squamous cell carcinoma of the uterine cervix. 2002 Br. J. Cancer pmid:11870519
Brooks LA et al. E7 proteins from oncogenic human papillomavirus types transactivate p73: role in cervical intraepithelial neoplasia. 2002 Br. J. Cancer pmid:11870517
Watermann DO et al. Specific induction of pp125 focal adhesion kinase in human breast cancer. 2005 Br. J. Cancer pmid:16136050
Ito Y et al. Polo-like kinase 1 overexpression is an early event in the progression of papillary carcinoma. 2004 Br. J. Cancer pmid:14735186
Prowatke I et al. Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays. 2007 Br. J. Cancer pmid:17146477
Theodore Ch et al. Bilateral germ-cell tumours: 22-year experience at the Institut Gustave Roussy. 2004 Br. J. Cancer pmid:14710206
Kostourou V et al. The role of tumour-derived iNOS in tumour progression and angiogenesis. 2011 Br. J. Cancer pmid:21139581
Lee JY et al. Farnesoid X receptor, overexpressed in pancreatic cancer with lymph node metastasis promotes cell migration and invasion. 2011 Br. J. Cancer pmid:21364590
Wu CF et al. Expression of parvin-beta is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract. 2010 Br. J. Cancer pmid:20736946
Rachagani S et al. Activated KrasG¹²D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin. 2011 Br. J. Cancer pmid:21364589
Cui T et al. DSC3 expression is regulated by p53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer. 2011 Br. J. Cancer pmid:21364582
Cemazar M et al. The endothelin B (ETB) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modification. 2005 Br. J. Cancer pmid:15970923
Verschoyle RD et al. Evaluation of the cancer chemopreventive efficacy of rice bran in genetic mouse models of breast, prostate and intestinal carcinogenesis. 2007 Br. J. Cancer pmid:17211473
Knijn N et al. KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients. 2011 Br. J. Cancer pmid:21364579
Cocco E et al. Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer. 2009 Br. J. Cancer pmid:19536090
Dangles V et al. Gene expression profiles of bladder cancers: evidence for a striking effect of in vitro cell models on gene patterns. 2002 Br. J. Cancer pmid:11953886
Staibano S et al. OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome. 2007 Br. J. Cancer pmid:17987038
Mellor P et al. Modulatory effects of heparin and short-length oligosaccharides of heparin on the metastasis and growth of LMD MDA-MB 231 breast cancer cells in vivo. 2007 Br. J. Cancer pmid:17726466
Yamamoto E et al. Expression of N-acetylglucosaminyltransferase V in endometrial cancer correlates with poor prognosis. 2007 Br. J. Cancer pmid:17971775
Jenkinson SR et al. S100A4 regulates cell motility and invasion in an in vitro model for breast cancer metastasis. 2004 Br. J. Cancer pmid:14710237
Jacques C et al. Death-associated protein 3 is overexpressed in human thyroid oncocytic tumours. 2009 Br. J. Cancer pmid:19536094
Al-Attar A et al. Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers. 2010 Br. J. Cancer pmid:20087352
Carpenter B et al. Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer. 2006 Br. J. Cancer pmid:16953238
Ugurel S et al. Lack of clinical efficacy of imatinib in metastatic melanoma. 2005 Br. J. Cancer pmid:15846297
Brown NS et al. Cooperative stimulation of vascular endothelial growth factor expression by hypoxia and reactive oxygen species: the effect of targeting vascular endothelial growth factor and oxidative stress in an orthotopic xenograft model of bladder carcinoma. 2005 Br. J. Cancer pmid:15841086
Chatrath P et al. Aberrant expression of minichromosome maintenance protein-2 and Ki67 in laryngeal squamous epithelial lesions. 2003 Br. J. Cancer pmid:12966424
Langbein S et al. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. 2006 Br. J. Cancer pmid:16465194
Wülfing P et al. Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ. 2005 Br. J. Cancer pmid:15841074
Kurokawa T et al. Overexpression of hypoxia-inducible-factor 1alpha(HIF-1alpha) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. 2003 Br. J. Cancer pmid:12966423
Hudelist G et al. Her-2/neu-triggered intracellular tyrosine kinase activation: in vivo relevance of ligand-independent activation mechanisms and impact upon the efficacy of trastuzumab-based treatment. 2003 Br. J. Cancer pmid:12966413
Larsson A et al. Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer. 2011 Br. J. Cancer pmid:21829192
Loubeyre P et al. Diagnostic precision of image-guided multisampling core needle biopsy of suspected lymphomas in a primary care hospital. 2009 Br. J. Cancer pmid:19401685
Seynhaeve AL et al. Isolated limb perfusion with actinomycin D and TNF-alpha results in improved tumour response in soft-tissue sarcoma-bearing rats but is accompanied by severe local toxicity. 2002 Br. J. Cancer pmid:11953868
Hartana CA et al. Detection of micrometastases by flow cytometry in sentinel lymph nodes from patients with renal tumours. 2016 Br. J. Cancer pmid:27599044
Lawrie LC et al. Liver fatty acid binding protein expression in colorectal neoplasia. 2004 Br. J. Cancer pmid:15138477
Fondevila C et al. p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer. 2004 Br. J. Cancer pmid:14710231
Modjtahedi H et al. Immunohistochemical discrimination of wild-type EGFR from EGFRvIII in fixed tumour specimens using anti-EGFR mAbs ICR9 and ICR10. 2012 Br. J. Cancer pmid:22315050
Hashida H et al. Clinical significance of transmembrane 4 superfamily in colon cancer. 2003 Br. J. Cancer pmid:12838318
Yamamoto T et al. No major tumorigenic role for beta-catenin in serrated as opposed to conventional colorectal adenomas. 2003 Br. J. Cancer pmid:12838317
Sersa G et al. Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. 2008 Br. J. Cancer pmid:18182988
Shyu RY et al. RARRES3 expression positively correlated to tumour differentiation in tissues of colorectal adenocarcinoma. 2003 Br. J. Cancer pmid:12838316
Benharroch D et al. Measles virus: evidence of an association with Hodgkin's disease. 2004 Br. J. Cancer pmid:15226778
de Graeff P et al. The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer. 2008 Br. J. Cancer pmid:18628764
Southern SA et al. Induction of tetrasomy by human papillomavirus type 16 E7 protein is independent of pRb binding and disruption of differentiation. 2004 Br. J. Cancer pmid:15138476